Skip to content
- Poly-ADP-ribose polymerase (PARP) inhibitors and ovarian function.
- Li J, Li Q, Zhang L, Zhang S, Dai Y.
- Biomed Pharmacother. 2022 Nov 18;157:114028. doi: 10.1016/j.biopha.2022.114028. Epub ahead of print.
- Role of Rucaparib in the Treatment of Prostate Cancer: Clinical Perspectives and Considerations.
- Wu MS, Goldberg H.
- Cancer Manag Res. 2022 Nov 15;14:3159-3174. doi: 10.2147/CMAR.S353411.
- [Breast and Advanced Ovarian Double Cancer with a BRCA2 Pathogenic Variant-A Case Report].
- Tanaka Y, Oota R, Takagi Y, Kodama W, Nishimura K, Hamasaki T, Fukino S, Suo K.
- Gan To Kagaku Ryoho. 2022 Nov;49(11):1271-1273. Japanese.
- Case report. [Article in Japanese]